Venture Capital

Atomwise Raises $123M To Accelerate Drug Discovery With Ai

by venturebeat.com posted 10months ago 54 views
Atomwise, a company leveraging AI and machine learning to accelerate drug discovery, has raised $123 million in venture capital. : Atomwise, a startup using AI to accelerate drug discovery, today secured $123 million in funding. A spokesperson said the funds will enable the startup to scale its technology and team as it expands its portfolio of joint ventures with researchers at the University of Toronto, Duke University School of Medicine, Charles River, Bayer, Eli Lilly, Merck, and others.

In this article